Raymond James & Associates’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History
Bought
Maintained
Sold
Other funds holding KURE
MMFA
MM
OMC
OPS
Raymond James & Associates's KURE Position: Q4 2021 in Review
Raymond James & Associates sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q4 2021, closing a stake of 6,460 shares — an estimated $242K sold.
Raymond James & Associates first reported a position in KURE in Q4 2020 and held it in 4 quarters. The position peaked at $294K in Q2 2021. 27 funds tracked by Wall St. Rank hold KURE as of Q4 2021.
- Raymond James & Associates reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q4 2021 after selling out during the quarter.
- Raymond James & Associates sold 6,460 KraneShares MSCI All China Health Care Index ETF shares in Q4 2021, an estimated $242K.
- Raymond James & Associates first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 4 quarters.
- Raymond James & Associates's KraneShares MSCI All China Health Care Index ETF position peaked at $294K in Q2 2021.
- 27 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q4 2021.
Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.